# Ebola Sudan Chimpanzee Adenovirus Vector Vaccine in Healthy Adults

> **NCT04041570** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 40 (actual)

## Conditions studied

- Ebola Virus

## Interventions

- **BIOLOGICAL:** cAd3-EBO S vaccine

## Key facts

- **NCT ID:** NCT04041570
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-02
- **Primary completion:** 2020-09-07
- **Final completion:** 2020-09-07
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04041570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04041570, "Ebola Sudan Chimpanzee Adenovirus Vector Vaccine in Healthy Adults". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04041570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*